Reduction of Drug Toxicity Using Dendrimers Based on Melamine
- 13 August 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 1 (5), 390-393
- https://doi.org/10.1021/mp049957p
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Dendrimers: a new class of nanoscopic containers and delivery devicesEuropean Polymer Journal, 2003
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Biological applications of dendrimersCurrent Opinion in Chemical Biology, 2002
- Dendritic polymer macromolecular carriers for drug deliveryCurrent Opinion in Chemical Biology, 2002
- Dendritic Polymers in Biomedical Applications: From Potential to Clinical Use in Diagnostics and TherapyAngewandte Chemie-International Edition, 2002
- Convergent Dendrons and Dendrimers: from Synthesis to ApplicationsChemical Reviews, 2001
- Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applicationsDrug Discovery Today, 2001
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000
- Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivoBioconjugate Chemistry, 1992